A New York City-based medtech startup called Ezra is about to replace pain inducing blood tests and biopsies with MRIs as part of its new prostate cancer screening subscription service, according to a recent report by TechCrunch.

When ultrasound reveals shoulder muscles that appear especially “bright,” it may be a warning sign of diabetes, according to findings to be presented at RSNA 2018 in Chicago.

A new special edition of the International Journal of Radiation Oncology•Biology•Physics will focus on imaging in radiation oncology, with more than 70 studies and essays available for free on the topic from Nov. 26-30.

“This technology can also be valuable to monitor high-risk patients who have increased risk of ovarian and breast cancers due to their genetic mutations,” Quing Zhu, PhD, and lead author of a recent Radiology study said.

Adding magnetic resonance spectroscopy (MRS) to MRI does not significantly improve the classification of brain tumors in clinical practice, although MRS may be a valuable supplement to MRI in certain cases, according to researchers from Sweden's Uppsala University.

The use of [18F]Fluciclovine-PET imaging is steadily increasing in patients with suspected prostate cancer, but a new single-center study published in the Journal of the American College of Radiology found some have more difficulty undergoing the exam than others.

A husband-and-wife research team at the University of Virginia (UVA) Cancer Center in Charlottesville, was awarded a five-year, $1.8 million grant from the National Institutes of Health (NIH) to improve their advanced radiation therapy technique for early-stage breast cancer patients, according to a UVA press release published Nov. 15.

A 15-minute MR spectroscopy scan can diagnose brain damage in newborns with 98 percent accuracy up to two years earlier than current methods, according to an Imperial College London (ICL) press release. The research was published online Nov. 14 in The Lancet Neurology.